Viewing Study NCT00367250


Ignite Creation Date: 2025-12-24 @ 4:57 PM
Ignite Modification Date: 2026-01-01 @ 11:57 PM
Study NCT ID: NCT00367250
Status: UNKNOWN
Last Update Posted: 2010-09-28
First Post: 2006-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer
Sponsor: Medical University of Vienna
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module